Marksans Pharma receives USFDA approval for Cetirizine Hydrochloride Tablets
It is indicated for the treatment of the perennial allergic rhinitis including sneezing, rhinorrhea, postnasal discharge, watery eyes, running nose. The product will be marketed under store brand labels and is comparable to the brand Zyrtec.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content